Adenocarcinoma, Mucinous - 21 Studies Found
| Recruiting |
: CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery :
|
| Active, not recruiting |
: Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer :
|
| Recruiting |
: Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab :
|
| Completed |
: A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer :
|
| Terminated |
: Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer :
|
| Terminated |
: Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer :
|
| Active, not recruiting |
: Low Rectal Cancer Study (MERCURY II) :
|
| Terminated |
: Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer :
|
| Active, not recruiting |
: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer :
|